The Biopharmaceuticals & Pharma team at Fresenius Kabi is responsible for the development, commercialization, and strategic management of biopharmaceutical and biosimilar products, with a focus on autoimmune diseases and oncology. This team ensures regulatory compliance, oversees intellectual property rights, drives market strategies, and supports the collection and analysis of clinical data to bring lifesaving biopharmaceutical solutions to patients in need.